Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-14 18:30 |
THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIA…
|
English | 212.6 KB | ||
| 2025-10-14 18:30 |
THX PHARMA (THERANEXUS) ET EXELTIS FRANCHISSENT UNE ÉTAPE MAJEURE VERS LA COMME…
|
French | 186.1 KB | ||
| 2025-09-29 18:30 |
Theranexus devient THX Pharma : une évolution stratégique vers la commercialisa…
|
French | 211.7 KB | ||
| 2025-09-29 18:30 |
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercializati…
|
English | 209.9 KB | ||
| 2025-05-13 18:00 |
THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-W…
|
English | 391.8 KB | ||
| 2025-05-13 18:00 |
THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE R…
|
French | 352.9 KB | ||
| 2025-04-29 19:05 |
URD 2024
|
French | 10.6 MB | ||
| 2025-04-29 19:00 |
THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT A…
|
English | 336.5 KB | ||
| 2025-04-29 19:00 |
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS E…
|
French | 297.3 KB | ||
| 2025-03-06 18:00 |
MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
|
French | 272.5 KB | ||
| 2025-01-23 18:15 |
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
|
English | 262.8 KB | ||
| 2025-01-23 18:00 |
THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2025
|
French | 254.5 KB | ||
| 2025-01-16 18:00 |
Information mensuelle relative au nombre total de droits de vote et d'actions c…
|
French | 168.8 KB | ||
| 2025-01-09 18:00 |
THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS
|
English | 179.9 KB | ||
| 2025-01-09 18:00 |
THERANEXUS ANNONCE LA PUBLICATION DE SA LETTRE AUX ACTIONNAIRES
|
French | 181.7 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
